co.don AG Share Price Xetra

Equities

CNW

DE000A3E5C08

Pharmaceuticals

Market Closed - Xetra 09:06:22 30/09/2022 pm IST 5-day change 1st Jan Change
0.245 EUR -28.99% Intraday chart for co.don AG -.--% -.--%

Financials

Sales 2020 62.33L 67.58L 56Cr Sales 2021 98.03L 1.06Cr 89Cr Capitalization 3.39Cr 3.67Cr 306.64Cr
Net income 2020 -1.3Cr -1.41Cr -117.62Cr Net income 2021 -90L -97.58L -81Cr EV / Sales 2020 6.74 x
Net cash position 2020 31.47L 34.12L 28Cr Net cash position 2021 3L 3L 2.65Cr EV / Sales 2021 3.43 x
P/E ratio 2020
-2.91 x
P/E ratio 2021
-3.8 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 38.31%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.25
Extreme 0.245
3.31
5 years
0.25
Extreme 0.245
8.54
10 years
0.25
Extreme 0.245
25.80
More quotes
Managers TitleAgeSince
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman - 29/05/29
Director/Board Member - 07/10/07
More insiders
Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.
More about the company

Annual profits - Rate of surprise